Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
about
Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorderStructural and functional studies on platelet-derived growth factorEffects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesisThymidine Phosphorylase in Cancer; Enemy or Friend?Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumorsThymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinomaTherapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in miceThymidine phosphorylase is angiogenic and promotes tumor growth.The role of DNA synthesis imaging in cancer in the era of targeted therapeuticsAlteration of nucleotide metabolism: a new mechanism for mitochondrial disorders.Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endotheliumThymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.Prognostic significance of angiogenesis in human pancreatic cancerPrediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: the influence of neoadjuvant treatment.TAS-102: a novel antimetabolite for the 21st century.Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug designAngiogenic growth factors in myocardial infarction: a critical appraisal.Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancerTumour vasculature--a potential therapeutic target.The role of growth factors in proliferative diabetic retinopathy.Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues.Purification, cloning, and expression of murine uridine phosphorylase.Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil.Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.Reinterpretation of the RACTK1 K+ channel.Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues.The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma.Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
P2860
Q22008732-4E4C5C91-8F4E-4645-BF74-C1C078EB5B76Q24555662-D6F44334-0CF4-439E-B19B-BFFFCD6FD5BAQ24678239-6C54F7F7-E0B5-4B30-AA19-86268461A741Q26795650-7947F2DF-EE10-48AF-B19F-5D3B7B2A6ACCQ28143681-53C0B04A-E430-4669-9601-CCDA19AB0C7FQ28211052-72154E46-BFF3-473E-BF96-4D79900B95FFQ33884698-45023BFB-A89B-4A9B-A38E-8A7A9E6612E9Q34363544-D1A5B179-040F-4DD9-B2FF-3EBBC5636BCDQ34441342-1F73F2B0-39EA-4750-B24E-7C2F0733D331Q34672542-FC5F1C95-FA4D-4299-A0E3-99A7C6F37266Q34907192-543DECDD-87D1-45EB-975F-41B581AAE323Q35206509-DEFADD6A-9ACA-430B-B12D-5F9E463CFD0BQ35754541-1DF08D89-8EE2-45E1-97F4-C3C197CC2FB0Q35951880-023A555D-052D-486D-86CE-2DD80EAA87C6Q36134978-13D9D0C2-78D9-4A3A-9DA6-496A3D2363A6Q36138649-B6DB9174-1195-435C-9F47-C29B52AF8A13Q36619020-7FF95775-88CF-4232-8BFD-EF9C098D8D44Q37513377-A603FB4B-C2C6-48EF-BD98-EC8403E48A49Q38308433-DA7CE840-3209-4BD9-AD35-110A870CA8E8Q38441129-72A7460C-E3DD-4B99-8730-48C12E2856B8Q38461166-0B10AE7D-4898-4747-B3FA-12A65860DBF4Q38652269-49214B2F-56D6-4191-8006-D41F4E2F958FQ38663123-1EB7DEB8-3B9C-47E4-98B0-1C740521235DQ39389842-C00178A9-BC6B-4DBD-901D-556E7CCE6AF6Q39713581-0737C144-3E0A-44C8-BF73-35562AD48F2BQ39714055-0A47062D-BFFB-4AFF-AE11-5FB5F4438F68Q40403280-503EB83A-D9D8-4189-ACD3-DC3460DFB1C1Q40442587-458B8873-0C67-404B-B8F3-FBD0E03BEBF8Q40589399-D7E1BE30-BEE4-4166-8266-FFB861C23707Q41344582-24FD9607-58F6-4746-81C1-EBA71959E6B4Q41601696-722199A6-B25B-481A-B49F-7C8851FA1D22Q41680050-B11C6C7B-7264-41C2-A8CE-618E3EF22786Q42056183-56B65A59-B9BC-4B2C-8591-1ECBDCE0856CQ42060633-FF92FB42-991B-4621-92A7-CBB79A025A38Q42072484-8D1368C5-2E21-488E-A71C-E7E2C253B06DQ42650597-46E53FB5-C63D-4D24-8305-E4E7D8183DB1Q43824298-2ACCED3C-D8DB-46EF-8AAF-EAD6485FAC0EQ43943699-F9B8B180-C818-4371-B43A-A8C430D5AF00Q44785500-FB00FC5A-07A0-47DC-8BB4-32DCD591AB59Q44881139-E3E5DF17-D2CC-467B-B4A0-ED885929140D
P2860
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
description
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1992
@ast
im Mai 1992 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1992/05/15)
@sk
vědecký článek publikovaný v roce 1992
@cs
wetenschappelijk artikel (gepubliceerd op 1992/05/15)
@nl
наукова стаття, опублікована в травні 1992
@uk
مقالة علمية (نشرت في 15-5-1992)
@ar
name
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@ast
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@en
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@nl
type
label
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@ast
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@en
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@nl
prefLabel
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@ast
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@en
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@nl
P2093
P921
P1476
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
@en
P2093
A. Thomason
C. H. Heldin
J. Waltenberger
K. Miyazono
P304
P356
10.1016/S0006-291X(05)80025-7
P407
P577
1992-05-15T00:00:00Z